News

Researchers at the Medical University of South Carolina and Clemson University report that they have developed human cardiac organoids to model myocardial infarction and drug cardiotoxicity.

A new study reveals that a protein known as APOBEC3A, which is responsible for genetic changes resulting in a variety of cancers, may also be the key to designing more effective targeted cancer therapies.

A research has proposed a new computational system to expand the understanding of the brain at an intermediate level, between neurons and cognitive phenomena such as language. The group has developed a brain architecture that is based on neuronal assemblies, and they demonstrate its use in the syntactic processing in the production of language.

A high-resolution structure of an activated dopamine receptor in its natural cell membrane environment, developed by researchers, could open up a new dimension in drug discovery for Parkinson’s disease.

The US Food and Drug Administration has approved nivolumab for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.

Scientists have discovered a potential new way to promote blood clotting that could be used to help develop treatments for Von Willebrand disease, a common genetic bleeding disorder.

A project initially focused on making better fluorescent tags has evolved into a novel method to kill tumors.

A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

A new combination of chemotherapy and immunotherapy shows promise for treating inoperable malignant pleural mesothelioma, according to new research.

A candidate treatment that utilizes cow antibodies to combat COVID-19 may be able to produce four times the level of neutralizing antibodies as seen in conventional human convalescent plasma serum, the compound's developer has announced.